Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Receivables - Other (2018 - 2019)

Historic Receivables - Other for Amicus Therapeutics (FOLD) over the last 2 years, with Q1 2019 value amounting to $9.0 million.

  • Amicus Therapeutics' Receivables - Other changed N/A to $9.0 million in Q1 2019 from the same period last year, while for Mar 2019 it was $9.0 million, marking a year-over-year change of. This contributed to the annual value of $9.0 million for FY2018, which is N/A changed from last year.
  • Per Amicus Therapeutics' latest filing, its Receivables - Other stood at $9.0 million for Q1 2019.
  • Amicus Therapeutics' 5-year Receivables - Other high stood at $9.0 million for Q4 2018, and its period low was $9.0 million during Q4 2018.